BR9003
/ Boryung Group
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
August 18, 2021
A Multi Doses Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects
(clinicaltrials.gov)
- P1; N=27; Completed; Sponsor: Boryung Pharmaceutical Co., Ltd; Recruiting ➔ Completed
Trial completion • Tobacco Cessation
July 20, 2021
A Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects
(clinicaltrials.gov)
- P1; N=24; Completed; Sponsor: Boryung Pharmaceutical Co., Ltd; Recruiting ➔ Completed
Clinical • Trial completion • Tobacco Cessation
April 23, 2021
A Multi Doses Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects
(clinicaltrials.gov)
- P1; N=24; Recruiting; Sponsor: Boryung Pharmaceutical Co., Ltd
Clinical • New P1 trial • Tobacco Cessation
April 15, 2021
A Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects
(clinicaltrials.gov)
- P1; N=24; Recruiting; Sponsor: Boryung Pharmaceutical Co., Ltd
New P1 trial • Tobacco Cessation
1 to 4
Of
4
Go to page
1